XY0VX83 ICD-10-PCS Code: Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3
Introduce Endoth Dmg Inhib Vn Grft New Tech 3
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | SectionX | New Technology |
| 2 | Body SystemY | Extracorporeal |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body PartV | Vein Graft |
| 5 | ApproachX | External |
| 6 | Device / Substance / Technology8 | Endothelial Damage Inhibitor |
| 7 | New Technology Group3 | New Technology Group 3 |
Related Codes
Same procedure category (CCSR), other tables
AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of therapeutic substances, NEC (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.
XW0J3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10, XW0J3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10, XW0J3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10, XW0K3HA — Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10, XW0K3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10, XW0K3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10, XW0K3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10, XW0L3HA — Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10, XW0L3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10, XW0L3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10, XW0L3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10, XW0M3HA — Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10, XW0M3JA — Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10, XW0M3KA — Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10, XW0M3LA — Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10, XW0Q316 — Introduction of Eladocagene exuparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 6, XW0U0XB — Introduction of Peptide Enhanced Bone Void Filler into Joints, Open Approach, New Technology Group 11, XW0U3XB — Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Approach, New Technology Group 11, XW0U4XB — Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Endoscopic Approach, New Technology Group 11, XW0V3WA — Introduction of AGN1 Bone Void Filler into Bones, Percutaneous Approach, New Technology Group 10, +265 more
Contextual Map
Every relationship of XY0VX83 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
PCS table
- XY0[PCS table]— CMS ICD-10-PCS tables
- New Technology — Section: New Technology[Section]: “New Technology”— CMS ICD-10-PCS tables
- Extracorporeal — Body System: Extracorporeal[Body System]: “Extracorporeal”— CMS ICD-10-PCS tables
- Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables
Clinical classification (CCSR)
- ADM021 — Administration of therapeutic substances, NEC[CCSR category]: “Administration of therapeutic substances, NEC — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1
Change history
No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.
Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels